Literature DB >> 17119008

Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.

Kazuyuki Ishida1, Hiroshi Mitoma, Yoshiaki Wada, Teruaki Oka, Junji Shibahara, Yuko Saito, Shigeo Murayama, Hidehiro Mizusawa.   

Abstract

Anti-glutamic acid decarboxylase antibody is associated with the development of progressive cerebellar ataxia and slowly progressive insulin-dependent diabetes mellitus. Previously, the neurophysiological characteristics of IgG in the cerebrospinal fluid of a patient with anti-glutamic acid decarboxylase antibody-associated progressive cerebellar ataxia and slowly progressive insulin-dependent diabetes mellitus were reported. Using a voltage-gated whole-cell recording technique, it was observed that the IgG in the cerebrospinal fluid of the patient selectively suppressed the inhibitory postsynaptic currents in the Purkinje cells. The patient died from aspiration pneumonia. Postmortem examination showed almost complete depletion of the Purkinje cells with Bergmann gliosis. Therefore, the main cause of cerebellar ataxia observed in this case may be attributed to the near-complete depletion of the Purkinje cells. In this paper, the pathomechanisms underlying Purkinje cell damage are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119008      PMCID: PMC2077656          DOI: 10.1136/jnnp.2006.091116

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells.

Authors:  R A Gatti; H V Vinters
Journal:  Kroc Found Ser       Date:  1985

2.  Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

Authors:  J Verschuuren; L Chuang; M K Rosenblum; F Lieberman; A Pryor; J B Posner; J Dalmau
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

3.  Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.

Authors:  K Ishida; H Mitoma; S Y Song; T Uchihara; A Inaba; S Eguchi; T Kobayashi; H Mizusawa
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

4.  Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells.

Authors:  M Warich-Kirches; P Von Bossanyi; T Treuheit; E Kirches; K Dietzmann; H Feistner; H Wittig
Journal:  Clin Neuropathol       Date:  1997 Jul-Aug       Impact factor: 1.368

5.  Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.

Authors:  A Saiz; J Arpa; A Sagasta; R Casamitjana; J J Zarranz; E Tolosa; F Graus
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

6.  Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.

Authors:  Michiel Coesmans; Peter A Sillevis Smitt; David J Linden; Ryuichi Shigemoto; Tomoo Hirano; Yoshinori Yamakawa; Adriaan M van Alphen; Chongde Luo; Josef N van der Geest; Johan M Kros; Carlo A Gaillard; Maarten A Frens; Chris I de Zeeuw
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

7.  Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus.

Authors:  K Nakanishi; T Kobayashi; H Miyashita; M Okubo; T Sugimoto; T Murase; K Kosaka; M Hara
Journal:  Metabolism       Date:  1993-02       Impact factor: 8.694

Review 8.  Glutamic acid decarboxylase autoantibodies and neurological disorders.

Authors:  M Vianello; B Tavolato; B Giometto
Journal:  Neurol Sci       Date:  2002-10       Impact factor: 3.307

9.  Stiff man syndrome: clinical and laboratory findings in eight patients.

Authors:  H M Meinck; K Ricker; P J Hülser; E Schmid; J Peiffer; M Solimena
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  J Seissler; J Amann; L Mauch; H Haubruck; S Wolfahrt; S Bieg; W Richter; R Holl; E Heinze; W Northemann
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  23 in total

1.  Selective loss of Purkinje cells in a patient with anti-gliadin-antibody-positive autoimmune cerebellar ataxia.

Authors:  Kazunori Nanri; Makoto Shibuya; Takeshi Taguchi; Akira Hasegawa; Nobuyuki Tanaka
Journal:  Diagn Pathol       Date:  2011-02-04       Impact factor: 2.644

Review 2.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

3.  Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

Authors:  Vincent Planche; Ana Marques; Miguel Ulla; Marc Ruivard; Franck Durif
Journal:  Cerebellum       Date:  2014-06       Impact factor: 3.847

4.  GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors:  Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal:  J Neurol       Date:  2013-10-05       Impact factor: 4.849

5.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors:  Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

Review 6.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

7.  Essential tremor is not a neurodegenerative disease.

Authors:  Ali H Rajput; Charles H Adler; Holly A Shill; Alex Rajput
Journal:  Neurodegener Dis Manag       Date:  2012-06

Review 8.  Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.

Authors:  Hiroshi Mitoma; Mario Manto
Journal:  Cerebellum       Date:  2022-01-22       Impact factor: 3.847

Review 9.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

10.  Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.

Authors:  Christiane S Hampe; Laura Petrosini; Paola De Bartolo; Paola Caporali; Debora Cutuli; Daniela Laricchiuta; Francesca Foti; Jared R Radtke; Veronika Vidova; Jérôme Honnorat; Mario Manto
Journal:  Orphanet J Rare Dis       Date:  2013-06-05       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.